Bicycle Therapeutics Management
Management criteria checks 3/4
Bicycle Therapeutics' CEO is Kevin Lee, appointed in Sep 2015, has a tenure of 8.58 years. total yearly compensation is $5.54M, comprised of 12.8% salary and 87.2% bonuses, including company stock and options. directly owns 0.53% of the company’s shares, worth €4.77M. The average tenure of the management team and the board of directors is 2.3 years and 4.8 years respectively.
Key information
Kevin Lee
Chief executive officer
US$5.5m
Total compensation
| CEO salary percentage | 12.8% |
| CEO tenure | 8.6yrs |
| CEO ownership | 0.5% |
| Management average tenure | 2.3yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$6m | US$710k | -US$181m |
| Sep 30 2023 | n/a | n/a | -US$162m |
| Jun 30 2023 | n/a | n/a | -US$140m |
| Mar 31 2023 | n/a | n/a | -US$124m |
| Dec 31 2022 | US$9m | US$673k | -US$113m |
| Sep 30 2022 | n/a | n/a | -US$101m |
| Jun 30 2022 | n/a | n/a | -US$87m |
| Mar 31 2022 | n/a | n/a | -US$78m |
| Dec 31 2021 | US$4m | US$677k | -US$67m |
| Sep 30 2021 | n/a | n/a | -US$66m |
| Jun 30 2021 | n/a | n/a | -US$62m |
| Mar 31 2021 | n/a | n/a | -US$56m |
| Dec 31 2020 | US$3m | US$592k | -US$51m |
| Sep 30 2020 | n/a | n/a | -US$38m |
| Jun 30 2020 | n/a | n/a | -US$37m |
| Mar 31 2020 | n/a | n/a | -US$35m |
| Dec 31 2019 | US$4m | US$517k | -US$31m |
| Sep 30 2019 | n/a | n/a | -US$33m |
| Jun 30 2019 | n/a | n/a | -US$31m |
| Mar 31 2019 | n/a | n/a | -US$26m |
| Dec 31 2018 | US$818k | US$386k | -US$22m |
Compensation vs Market: Kevin's total compensation ($USD5.54M) is above average for companies of similar size in the German market ($USD1.28M).
Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.
CEO
Kevin Lee (55 yo)
8.6yrs
Tenure
US$5,540,400
Compensation
Dr. Kevin Lee, M.B.A., Ph D., has been Chief Executive Officer of Bicycle Therapeutics plc since September 2015. Dr. Lee joined Bicycle Therapeutics from Pfizer where he served as Senior Vice President and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 8.6yrs | US$5.54m | 0.53% $ 4.8m | |
| Co-Founder & Non-Executive Director | no data | US$477.04k | 0.38% $ 3.5m | |
| Chief Financial Officer | less than a year | US$2.88m | no data | |
| Chief Development Officer | 1.1yrs | US$2.82m | 0% $ 0 | |
| President | no data | US$3.07m | 0.0059% $ 52.9k | |
| Scientific Founder | no data | no data | no data | |
| Chief Operating Officer | 2.3yrs | US$5.98m | 0.034% $ 310.3k | |
| Senior VP | less than a year | no data | 0.0043% $ 38.5k | |
| Chief Technology Officer | 2.3yrs | US$3.07m | 0.11% $ 1.0m | |
| Chief Scientific Officer | 7.3yrs | no data | 0.054% $ 491.6k | |
| General Counsel | 4yrs | no data | no data | |
| Senior Vice President of Capital Markets & Corporate Communications | no data | no data | no data |
2.3yrs
Average Tenure
53.5yo
Average Age
Experienced Management: 50BA's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 8.6yrs | US$5.54m | 0.53% $ 4.8m | |
| Co-Founder & Non-Executive Director | no data | US$477.04k | 0.38% $ 3.5m | |
| Chairman of Scientific Advisory Board | 5.9yrs | no data | no data | |
| Non-Executive Chairman | 5.1yrs | US$1.06m | 0% $ 0 | |
| Independent Non-Executive Director | 4.5yrs | US$492.79k | 0% $ 0 | |
| Independent Non-Executive Director | 4.8yrs | US$526.91k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.5yrs | no data | no data | |
| Independent Non-Executive Director | 4.8yrs | US$495.41k | 0% $ 0 | |
| Member of Scientific Advisory Board | 5.9yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.5yrs | no data | no data |
4.8yrs
Average Tenure
67yo
Average Age
Experienced Board: 50BA's board of directors are considered experienced (4.8 years average tenure).